OIG re­port ac­cus­es FDA of not fol­low­ing poli­cies for for­eign drug in­spec­tions

A new re­port from the US De­part­ment of Health and Hu­man Ser­vices’ Of­fice of In­spec­tor Gen­er­al ac­cus­es the FDA of not fol­low­ing its poli­cies around for­eign drug in­spec­tions, and rec­om­mends some im­prove­ments.

The OIG re­port, re­leased on Thurs­day, found that the FDA has not al­ways fol­lowed its poli­cies and pro­ce­dures for for­eign for-cause drug in­spec­tions, and that the agency al­leged­ly mis­placed doc­u­ments to prove its lead in­ves­ti­ga­tors com­plet­ed their re­quired train­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.